Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee (IBC) is the university’s administrative and decision-making body responsible for reviewing and approving research involving recombinant or synthetic nucleic acid molecules and other biohazardous materials. IBC approval is required before any work with covered materials may begin. The IBC’s operations are supported and administered by the Division of Research.

Meeting Dates:

• March 18, 2026

Meeting Minutes:

Effective June 1, 2025 (per NIH NOT-OD-25-082 and the NIH Guidelines), BGSU will publicly post approved IBC meeting minutes for activities involving recombinant or synthetic nucleic acid molecules.

• Meeting Minutes Download Area (Note: No IBC meetings addressing recombinant or synthetic nucleic acid molecules have occurred since June 1, 2025; approved minutes will be posted here when available.)

Resources:

• NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules ("NIH Guidelines")
• Biosafety in Microbiological and Biomedical Laboratories (6th Edition)

Who can I contact if I have a question about the use of Recombinant or Synthetic Nucleic Acid Molecules or Biohazardous Materials?

• Institutional Biosafety Committee (IBC)
• ibc@bgsu.edu
• 419-372-2484